UNH250110C495000
- 27.10
- +3.59+15.27%
UnitedHealth Newsroom
Truist Financial Maintains UnitedHealth(UNH.US) With Buy Rating, Announces Target Price $610
Truist Securities Maintains Buy on UnitedHealth Group, Lowers Price Target to $610
UnitedHealth Group Analyst Ratings
Piper Sandler Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $600
Piper Sandler Maintains Overweight on UnitedHealth Group, Lowers Price Target to $600
UnitedHealth Group Analyst Ratings
Raymond James Maintains UnitedHealth(UNH.US) With Buy Rating
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $655
Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS) and UnitedHealth (UNH)
Bernstein Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $658
Morgan Stanley Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $610
Morgan Stanley Sticks to Its Buy Rating for UnitedHealth (UNH)
Bernstein Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $658
Bernstein Reaffirms Their Buy Rating on UnitedHealth (UNH)
Bernstein Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $658
Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX), UnitedHealth (UNH) and Disc Medicine (IRON)
Jefferies Maintains UnitedHealth(UNH.US) With Buy Rating, Cuts Target Price to $635
UnitedHealth Price Target Raised to $640.00/Share From $610.00 by Oppenheimer
UnitedHealth Is Maintained at Outperform by Oppenheimer
Cantor Fitzgerald Adjusts Price Target on UnitedHealth Group to $700 From $644